nach oben

Erschienen in:

18.03.2019 | Proceeding of the North American Society of Head and Neck Pathology Companion Meeting, March 17, 2019, National Harbor, MD

Oral Epithelial Dysplasia and Premalignancy

verfasst von: Sook-Bin Woo

Erschienen in: Head and Neck Pathology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Leukoplakia and erythroplakia are two entities under the moniker of “oral potentially malignant disorders” that are highly associated with the presence of oral epithelial dysplasia (OED) at first biopsy, while lesions of submucous fibrosis develop OED after being present for years. Importantly, traumatic/frictional keratoses are often mistaken clinically for leukoplakia and it is important for the pathologist to recognize and report them as such. The features of OED have been well-described and other architectural features will be discussed here, in particular verrucous and papillary architecture, bulky epithelial proliferation and epithelial atrophy. Proliferative leukoplakia, verrucous or otherwise, often show only hyperkeratosis in early lesions, with development of OED occurring over time, and squamous cell carcinoma developing in the majority of cases over time. The concept of hyperkeratosis without features of OED and that is not reactive, is likely a precursor to the dysplastic phenotype. Many cases of leukoplakia exhibiting OED are associated with a band of lymphocytes at the interface and these should not be mistaken for oral lichen planus.

Reibel J, Gale N, Hille J, Hunt JL, Lingen M, Muller S, et al. Oral potentially malignant disorders and oral epithelial dysplasia. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg P, editors. WHO classification of head and neck tumours. 4th ed. Lyon: iaRC; 2017. pp. 112–5.

Muller S. Oral lichenoid lesions: distinguishing the benign from the deadly. Mod Pathol. 2017;30(s1):54–67. https://doi.org/10.1038/modpathol.2016.121.CrossRef

Fitzpatrick SG, Honda KS, Sattar A, Hirsch SA. Histologic lichenoid features in oral dysplasia and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(4):511–20. https://doi.org/10.1016/j.oooo.2013.12.413.CrossRefPubMed

Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol oral Radiol. 2018;125(6):612–27. https://doi.org/10.1016/j.oooo.2017.12.011.CrossRefPubMed

Shafer WG, Waldron CA. Erythroplakia of the oral cavity. Cancer. 1975;36:1021–8.CrossRefPubMed

Mashberg A, Feldman LJ. Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited. Am J Surg. 1988;156(4):273–5.CrossRefPubMed

Reichart PA, Philipsen HP. Oral erythroplakia—a review. Oral Oncol. 2005;41(6):551–61. https://doi.org/10.1016/j.oraloncology.2004.12.003.CrossRefPubMed

Guha N, Warnakulasuriya S, Vlaanderen J, Straif K. Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control. Int J Cancer. 2014;135(6):1433–43. https://doi.org/10.1002/ijc.28643.CrossRefPubMed

Tilakaratne WM, Ekanayaka RP, Warnakulasuriya S. Oral submucous fibrosis: a historical perspective and a review on etiology and pathogenesis. Oral surgery, oral medicine. Oral Pathol Oral Radiol. 2016;122(2):178–91. https://doi.org/10.1016/j.oooo.2016.04.003.CrossRef

10.

Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575–80.CrossRefPubMed

11.

Pentenero M, Meleti M, Vescovi P, Gandolfo S. Oral proliferative verrucous leukoplakia: are there particular features for such an ambiguous entity? Systematic review. Br J Dermatol. 2014. https://doi.org/10.1111/bjd.12853.CrossRefPubMed

12.

Abadie WM, Partington EJ, Fowler CB, Schmalbach CE. Optimal management of proliferative verrucous leukoplakia: a systematic review of the literature. Otolaryngol Head Neck Surg. 2015;153(4):504–11. https://doi.org/10.1177/0194599815586779.CrossRefPubMed

13.

Villa A, Menon RS, Kerr AR, De Abreu Alves F, Guollo A, Ojeda D, et al. Proliferative leukoplakia: proposed new clinical diagnostic criteria. Oral Dis. 2018;24(5):749–60. https://doi.org/10.1111/odi.12830.CrossRefPubMed

14.

Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC, et al. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res. 2002;62(18):5295–300.PubMed

15.

Okoturo EM, Risk JM, Schache AG, Shaw RJ, Boyd MT. Molecular pathogenesis of proliferative verrucous leukoplakia: a systematic review. Br J Oral Maxillofac Surg. 2018;56(9):780–5. https://doi.org/10.1016/j.bjoms.2018.08.010.CrossRefPubMed

16.

Lumerman HS, Freedman PD, Kerpel SM, Cale AE. Screening for oral hairy leukoplakia by cytologic examination. Diagn Cytopathol. 1990;6(3):225.CrossRefPubMed

17.

Arduino PG, Bagan J, El-Naggar AK, Carrozzo M. Urban legends series: oral leukoplakia. Oral Dis. 2013;19(7):642–59. https://doi.org/10.1111/odi.12065.CrossRefPubMed

18.

Ho MW, Risk JM, Woolgar JA, Field EA, Field JK, Steele JC, et al. The clinical determinants of malignant transformation in oral epithelial dysplasia. Oral Oncol. 2012;48(10):969–76. https://doi.org/10.1016/j.oraloncology.2012.04.002.CrossRefPubMed

19.

Feller L, Altini M, Slabbert H. Pre-malignant lesions of the oral mucosa in a South African sample—a clinicopathological study. J Dent Assoc S Afr. 1991;46(5):261–5.PubMed

20.

Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 1998;34(4):270–5.CrossRefPubMed

21.

Brouns E, Baart J, Karagozoglu K, Aartman I, Bloemena E, van der Waal I. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis. 2014;20(3):e19–24. https://doi.org/10.1111/odi.12095.CrossRefPubMed

22.

Lee JJ, Hung HC, Cheng SJ, Chen YJ, Chiang CP, Liu BY, et al. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(4):472–80. https://doi.org/10.1016/j.tripleo.2005.07.024.CrossRefPubMed

23.

Woo SB, Grammer RL, Lerman MA. Keratosis of unknown significance and leukoplakia: a preliminary study. Oral Surg Oral Med Oral Pathol oral Radiol. 2014;118(6):713–24. https://doi.org/10.1016/j.oooo.2014.09.016.CrossRefPubMed

24.

Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. Cancer. 1984;53:563–8.CrossRefPubMed

25.

Woo SB, Lin D. Morsicatio mucosae oris–a chronic oral frictional keratosis, not a leukoplakia. J Oral Maxillofac Surg. 2009;67(1):140–6. https://doi.org/10.1016/j.joms.2008.08.040.CrossRefPubMed

26.

Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc. 2014;145(1):45–56. https://doi.org/10.14219/jada.2013.10.CrossRefPubMed

27.

Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS, et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol. 2017;68:92–102. https://doi.org/10.1016/j.oraloncology.2017.03.012.CrossRefPubMed

28.

Cheng YS, Gould A, Kurago Z, Fantasia J, Muller S. Diagnosis of oral lichen planus: a position paper of the American Academy of Oral and Maxillofacial Pathology. Oral Surg Oral Med Oral Pathol oral Radiol. 2016;122(3):332–54. https://doi.org/10.1016/j.oooo.2016.05.004.CrossRefPubMed

29.

Natarajan E, Woo SB. Benign alveolar ridge keratosis (oral lichen simplex chronicus): a distinct clinicopathologic entity. J Am Acad Dermatol. 2008;58(1):151–7.CrossRefPubMed

30.

Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 2006;42(10):987–93. https://doi.org/10.1016/j.oraloncology.2005.12.014.CrossRefPubMed

31.

Kujan O, Khattab A, Oliver RJ, Roberts SA, Thakker N, Sloan P. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation. Oral Oncol. 2007;43(3):224–31. https://doi.org/10.1016/j.oraloncology.2006.03.009.CrossRefPubMed

32.

Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008;37(3):127–33. https://doi.org/10.1111/j.1600-0714.2007.00584.x.CrossRefPubMed

33.

Hansen LS, Olson JA Jr. SS. Proliferative verrucous leukoplakia. Oral Surg Oral Med Oral Pathol. 1985;60:285–98.CrossRefPubMed

34.

Wang YP, Chen HM, Kuo RC, Yu CH, Sun A, Liu BY, et al. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications. J Oral Pathol Med. 2009;38(8):651–6. https://doi.org/10.1111/j.1600-0714.2009.00790.x.CrossRefPubMed

35.

Zain RB, K TG, Ramanathan A, Kim J, Tilakaratne WM, Takata T, et al. Exophytic verrucous hyperplasia of the oral cavity—application of standardized criteria for diagnosis from a consensus report. Asian Pac J Cancer Prevent: APJCP. 2016;17(9):4491–501.

36.

Muller S. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):591–602. https://doi.org/10.1016/j.oooo.2018.02.012.CrossRefPubMed

37.

Lerman MA, Almazrooa S, Lindeman N, Hall D, Villa A, Woo SB. HPV-16 in a distinct subset of oral epithelial dysplasia. Mod Pathol. 2017;30(12):1646–54. https://doi.org/10.1038/modpathol.2017.71.CrossRefPubMed

38.

Klanrit P, Sperandio M, Brown AL, Shirlaw PJ, Challacombe SJ, Morgan PR, et al. DNA ploidy in proliferative verrucous leukoplakia. Oral Oncol. 2007;43(3):310–6. https://doi.org/10.1016/j.oraloncology.2006.03.016.CrossRefPubMed

39.

Gouvea AF, Santos Silva AR, Speight PM, Hunter K, Carlos R, Vargas PA, et al. High incidence of DNA ploidy abnormalities and increased Mcm2 expression may predict malignant change in oral proliferative verrucous leukoplakia. Histopathology. 2013;62(4):551–62. https://doi.org/10.1111/his.12036.CrossRefPubMed

40.

Abbas NF, Labib El-Sharkawy S, Abbas EA, Abdel Monem El-Shaer M. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(3):385–90. https://doi.org/10.1016/j.tripleo.2005.11.008.CrossRefPubMed

41.

Shahnavaz SA, Regezi JA, Bradley G, Dube ID, Jordan RC. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas. J Pathol. 2000;190(4):417–22. https://doi.org/10.1002/(SICI)1096-9896(200003)190:4%3C417::AID-PATH544%3E3.0.CO;2-G.CrossRefPubMed

42.

Nikitakis NG, Rassidakis GZ, Tasoulas J, Gkouveris I, Kamperos G, Daskalopoulos A, et al. Alterations in the expression of DNA damage response-related molecules in potentially preneoplastic oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):637–49. https://doi.org/10.1016/j.oooo.2018.03.006.CrossRefPubMed

43.

Vogelstein B, Kinzler KW. The path to cancer—three strikes and you’re out. N Engl J Med. 2015;373(20):1895–8. https://doi.org/10.1056/NEJMp1508811.CrossRefPubMed

44.

van der Meij EH, Mast H, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol. 2007;43(8):742–8. https://doi.org/10.1016/j.oraloncology.2006.09.006.CrossRefPubMed

45.

Brandwein-Gensler M, Smith RV, Wang B, Penner C, Theilken A, Broughel D, et al. Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol. 2010;34(5):676–88. https://doi.org/10.1097/PAS.0b013e3181d95c37.CrossRefPubMed

46.

Hanna GJ, Kofman ER, Shazib MA, Woo SB, Reardon B, Treister NS, et al. Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors. Oral Oncol. 2018;81:1–9. https://doi.org/10.1016/j.oraloncology.2018.04.007.CrossRefPubMed

Titel: Oral Epithelial Dysplasia and Premalignancy
verfasst von: Sook-Bin Woo
Publikationsdatum: 18.03.2019
Verlag: Springer US
Erschienen in: Head and Neck Pathology / Ausgabe 3/2019
Elektronische ISSN: 1936-0568
DOI: https://doi.org/10.1007/s12105-019-01020-6

Neu im Fachgebiet Pathologie

01.04.2024 | Forensische Traumatologie | CME

Springer Medizin

Oral Epithelial Dysplasia and Premalignancy

Abstract

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Aneurysmal Bone Cyst of the Maxillary Sinus with USP6 Rearrangement: Case Report of a Rare Entity and Review of the Literature

Current Challenges in the Staging of Oral Cancer

Seventeen New Cases of Chronic Ulcerative Stomatitis with Literature Review

Challenges in Minor Salivary Gland Biopsies: A Practical Approach to Problematic Histologic Patterns

Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases

Identifying Candidate Biomarkers for Pleomorphic Adenoma: A Case–Control Study

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien